226 related articles for article (PubMed ID: 33351619)
1. Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space.
Schwaid AG; Spencer KB
J Med Chem; 2021 Jan; 64(1):101-122. PubMed ID: 33351619
[TBL] [Abstract][Full Text] [Related]
2. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress.
Xu Y; Yuan Q; Cao S; Cui S; Xue L; Song X; Li Z; Xu R; Yuan Q; Li R
Biochem Biophys Res Commun; 2020 Sep; 529(4):998-1004. PubMed ID: 32819611
[TBL] [Abstract][Full Text] [Related]
6. Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction.
Boini KM; Hussain T; Li PL; Koka S
Cell Physiol Biochem; 2017; 44(1):152-162. PubMed ID: 29130962
[TBL] [Abstract][Full Text] [Related]
7. Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases.
Zhang X; Xu A; Lv J; Zhang Q; Ran Y; Wei C; Wu J
Eur J Med Chem; 2020 Jan; 185():111822. PubMed ID: 31699536
[TBL] [Abstract][Full Text] [Related]
8. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
[TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock.
Gong Z; Zhou J; Li H; Gao Y; Xu C; Zhao S; Chen Y; Cai W; Wu J
Mol Nutr Food Res; 2015 Nov; 59(11):2132-42. PubMed ID: 26250869
[TBL] [Abstract][Full Text] [Related]
10. Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis.
Yang G; Lee HE; Moon SJ; Ko KM; Koh JH; Seok JK; Min JK; Heo TH; Kang HC; Cho YY; Lee HS; Fitzgerald KA; Lee JY
Arthritis Rheumatol; 2020 Jul; 72(7):1192-1202. PubMed ID: 32134203
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory effects of baicalin through suppression of NLRP3 inflammasome pathway in LPS-challenged piglet mononuclear phagocytes.
Ye C; Li S; Yao W; Xu L; Qiu Y; Liu Y; Wu Z; Hou Y
Innate Immun; 2016 Apr; 22(3):196-204. PubMed ID: 26865578
[TBL] [Abstract][Full Text] [Related]
12. Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1.
Zorman J; Sušjan P; Hafner-Bratkovič I
PLoS One; 2016; 11(7):e0159826. PubMed ID: 27467658
[TBL] [Abstract][Full Text] [Related]
13. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
14. Naloxone inhibits nod-like receptor protein 3 inflammasome.
Lin HY; Chang YY; Kao MC; Huang CJ
J Surg Res; 2017 Nov; 219():72-77. PubMed ID: 29078913
[TBL] [Abstract][Full Text] [Related]
15. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.
Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD
Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047
[TBL] [Abstract][Full Text] [Related]
16. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
Buckley LF; Libby P
J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 Inflammasome-Mediated Inflammation in Acute Pancreatitis.
Ferrero-Andrés A; Panisello-Roselló A; Roselló-Catafau J; Folch-Puy E
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751171
[TBL] [Abstract][Full Text] [Related]
20. The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.
Jiang H; Gong T; Zhou R
Adv Immunol; 2020; 145():55-93. PubMed ID: 32081200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
